Integrating Tobacco Use Assessment and Treatment in the Oncology Setting: Quality Improvement Results from the Georgetown Lombardi Smoking Treatment and Recovery Program
Current Oncology · 28.03.2023 · 30 (4) · 3755-3775
DOI: 10.3390/curroncol30040285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 28.03.2023. Verfasst von Kathryn L Taylor und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA. Hauptthemen laut MEDLINE: Smoking Cessation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute of the National Institutes of Health, MedStar Health, CVS Health.
Abstract (Originalsprache)
As part of the NCI’s Cancer Center Cessation (C3i) initiative, we initiated, expanded, and maintained an evidence-based tobacco treatment program at the Georgetown Lombardi Comprehensive Cancer Center. We present a quality improvement (QI) assessment of the implementation process and patient-level outcomes. At two hematology/oncology outpatient clinical sites, five oncology-based teams (clinical administrators, clinical staff, pharmacy, information technology, and tobacco treatment staff) developed implementation strategies for opt-out patient assessment and enrollment, centralized tobacco treatment, audit, feedback, and staff training. Among eligible patients (tobacco use in ≤30 days), we assessed demographic, clinical, and tobacco-related characteristics to examine predictors of enrollment (baseline completed), treatment engagement (≥one sessions completed), and self-reported 7-day abstinence (6 months post-enrollment). Across both sites, medical assistants screened 19,344 (82.4%) patients for tobacco use, which identified 1345 (7.0%) current tobacco users, in addition to 213 clinician referrals. Of the 687/1256 (54.7%) eligible patients reached, 301 (43.8%) enrolled, and 199 (29.0%) engaged in treatment, of whom 74.5% were African American and 68% were female. At the larger site, significant multivariate predictors of enrollment included African American race (vs. white/other) and clinician referral (vs. MA assessment). Treatment engagement was predicted by greater nicotine dependence, and abstinence (27.4%) was predicted by greater treatment engagement. In summary, the systematic utilization of multiple oncology-based teams and implementation strategies resulted in the development and maintenance of a high-quality, population-based approach to tobacco treatment. Importantly, these strategies addressed inequities in tobacco treatment, as the program reached and engaged a majority-African-American patient population. Finally, the opt-out patient assessment strategy has been implemented in multiple oncology settings at MedStar Health through the Commission on Cancer’s Just Ask program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
- Department of Psychiatry, Georgetown University Hospital, MedStar Health, Washington, DC 20007, USA.
- Department of Pulmonary Medicine, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
- Department of Medical Oncology, MedStar Georgetown University Hospital, Washington, DC 20007, USA.
- Department of Medical Oncology, MedStar Washington Hospital Center, Washington, DC 20010, USA.
- Department of Medicine, Georgetown University Medical Center, Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA.
ORCID-Profile: Kathryn L Taylor, Julia M Whealan, Tania Lobo, Randi M Williams
Förderung
- NCI NIH HHS
- National Cancer Institute of the National Institutes of Health
- MedStar Health, CVS Health
- Lombardi Comprehensive Cancer Center’s Survey, Recruitment, and Biospecimen Shared Resource
Zitieren
APA
Taylor, K. L., Webster, M. A., Philips, J. G., Whealan, J. M., Lobo, T., Davis, K. M., Breece, C. J., Wheeley, J. R., Childs, J. E., Le, A. Q., Williams, R. M., Veytsman, I. G., & Kim, C. (2023). Integrating Tobacco Use Assessment and Treatment in the Oncology Setting: Quality Improvement Results from the Georgetown Lombardi Smoking Treatment and Recovery Program. Current Oncology, 30(4), 3755-3775. https://doi.org/10.3390/curroncol30040285
Vancouver
Taylor KL, Webster MA, Philips JG, Whealan JM, Lobo T, Davis KM, et al. Integrating Tobacco Use Assessment and Treatment in the Oncology Setting: Quality Improvement Results from the Georgetown Lombardi Smoking Treatment and Recovery Program. Current Oncology. 2023;30(4):3755-3775. doi:10.3390/curroncol30040285
BibTeX
@article{Taylor2023,
author = {Taylor, Kathryn L and Webster, Marguerite A and Philips, Joanna G and Whealan, Julia M and Lobo, Tania and Davis, Kimberly M and Breece, Chavalia J and Wheeley, Jennifer R and Childs, Jack E and Le, Ariel Q and Williams, Randi M and Veytsman, Irina G and Kim, Chul},
title = {Integrating Tobacco Use Assessment and Treatment in the Oncology Setting: Quality Improvement Results from the Georgetown Lombardi Smoking Treatment and Recovery Program},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {4},
pages = {3755--3775},
doi = {10.3390/curroncol30040285}
}
EUVIMED